A Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01035216
Recruitment Status : Terminated (This study has been terminated.)
First Posted : December 18, 2009
Last Update Posted : December 23, 2014
Information provided by:
SBI Biotech Co., Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : November 2013
  Study Completion Date : November 2013